GlassScriptPhysician profile
Lalitha Raguthu
NPI 1851558480
$523.93
in general payments reported to CMS, 2019-2025
9 companies · $107 in 2025
The $107 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.57 · 2020: $44.38 · 2021: $40.84 · 2022: $28.70 · 2023: $33.34 · 2024: $173 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $313.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $132.00 | 2019-2024 | Immunocap |
| Verrica Pharmaceuticals INC. | $106.00 | 2024-2025 | Ycanth |
| Cranial Technologies, INC | $91.95 | 2020-2025 | Doc Band |
| Glaxosmithkline, LLC. | $68.04 | 2019-2025 | Bexsero |
| Merck Sharp & Dohme LLC | $30.53 | 2021-2024 | Gardasil, Gardasil 9, Vaxneuvance |
| Abbvie INC. | $29.26 | 2021-2022 | |
| Alk-Abello, INC | $26.61 | 2025 | Ragwitek, Odactra, Grastek |
| Pfizer INC. | $20.19 | 2024 | |
| Sanofi-Aventis U.S. LLC | $19.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lalitha Raguthu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.